DKSH is expanding its pharmaceutical ingredients business in Thailand with the acquisition of P.R. Chemicals Company Limited, a Bangkok-based distributor specializing in Active Pharmaceutical Ingredients (APIs).

 

Under the agreement, DKSH will acquire 100% of P.R. Chemicals and integrate the business into its existing operations. The deal is expected to close in the fourth quarter of 2026, subject to customary closing conditions.

 

The acquisition will strengthen DKSH Performance Materials’ API platform and expand its portfolio of healthcare-related specialty ingredients. It also gives DKSH opportunities to broaden customer coverage, cross-sell products and expand its offering to pharmaceutical manufacturers in Thailand.

 

Peerut Sunirand, Managing Director of P.R. Chemicals, commented: “Since its founding in 1984, P.R. Chemicals has grown into a trusted partner for pharmaceutical manufacturers across Thailand. We believe DKSH is the right long-term home for our business, our employees, and our partners. Together, we can continue building on our strong foundation and unlock new growth opportunities.”

 

Natale Capri, Head Business Unit Performance Materials at DKSH, added: “The acquisition of P.R. Chemicals marks another milestone in the growth of our pharmaceutical portfolio. The company brings strong technical expertise, long-standing client and customer relationships, and a complementary product portfolio. By joining forces, we will strengthen our capabilities in Thailand, broaden our reach in the pharmaceutical industry, and create new opportunities for sustainable growth across Southeast Asia.”

 

The deal further positions DKSH to expand its pharmaceutical ingredients business in Thailand while supporting its broader growth ambitions across Southeast Asia.